Published in Ann Surg Oncol on July 01, 2001
EANM-EORTC general recommendations for sentinel node diagnostics in melanoma. Eur J Nucl Med Mol Imaging (2009) 1.68
Feasibility of sentinel node biopsy in head and neck melanoma using a hybrid radioactive and fluorescent tracer. Ann Surg Oncol (2011) 1.25
Concomitant radio- and fluorescence-guided sentinel lymph node biopsy in squamous cell carcinoma of the oral cavity using ICG-(99m)Tc-nanocolloid. Eur J Nucl Med Mol Imaging (2012) 1.15
Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma. Ann Surg Oncol (2009) 1.14
Clinical trial of combined radio- and fluorescence-guided sentinel lymph node biopsy in breast cancer. Br J Surg (2013) 1.14
The Hybrid SPECT/CT as an additional lymphatic mapping tool in patients with breast cancer. World J Surg (2008) 1.02
Sentinel node biopsy in melanoma: technical considerations of the procedure as performed at the John Wayne Cancer Institute. J Surg Oncol (2010) 1.00
The yield of SPECT/CT for anatomical lymphatic mapping in patients with breast cancer. Eur J Nucl Med Mol Imaging (2009) 0.90
An evaluation of molecular markers for improved detection of breast cancer metastases in sentinel nodes. J Clin Pathol (2006) 0.90
Lymphatic drainage patterns from melanomas on the shoulder or upper trunk to cervical lymph nodes and implications for the extent of neck dissection. Ann Surg Oncol (2012) 0.85
Sentinel node detection in head and neck malignancies: innovations in radioguided surgery. J Oncol (2009) 0.84
Lymphoscintigraphy and radioguided sentinel node biopsy in oral cavity squamous cell carcinoma: same day protocol. Eur Arch Otorhinolaryngol (2006) 0.83
EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma. Eur J Nucl Med Mol Imaging (2015) 0.83
Sentinel Lymph Node Biopsy in Vulvar Cancer Using Combined Radioactive and Fluorescence Guidance. Int J Gynecol Cancer (2015) 0.82
Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma. Eur J Nucl Med Mol Imaging (2009) 0.80
The next evolution in radioguided surgery: breast cancer related sentinel node localization using a freehandSPECT-mobile gamma camera combination. Am J Nucl Med Mol Imaging (2015) 0.79
The hidden sentinel node and SPECT/CT in breast cancer patients. Eur J Nucl Med Mol Imaging (2008) 0.76
Nodal status assessment in breast cancer: strategies of clinical grounds and quality of life implications. Int J Breast Cancer (2014) 0.76
In breast cancer patients sentinel lymph node metastasis characteristics predict further axillary involvement. Virchows Arch (2014) 0.76
The use of SPECT/CT for anatomical mapping of lymphatic drainage in vulvar cancer: possible implications for the extent of inguinal lymph node dissection. Eur J Nucl Med Mol Imaging (2015) 0.76
Sentinel lymph node mapping in colon cancer. Surg Endosc (2004) 0.75
Sentinel node biopsy during thoracolaparoscopic esophagectomy for advanced esophageal cancer. World J Surg Oncol (2016) 0.75
Contribution of SPECT/CT for sentinel node localization in patients with ipsilateral breast cancer relapse. Eur J Nucl Med Mol Imaging (2016) 0.75
Beyond penile cancer, is there a role for sentinel node biopsy in urological malignancies? Clin Transl Imaging (2016) 0.75
Prediction of sentinel lymph node status using single-photon emission computed tomography (SPECT)/computed tomography (CT) imaging of breast cancer. Surg Today (2015) 0.75
Sentinel node detection in muscle-invasive urothelial bladder cancer is feasible after neoadjuvant chemotherapy in all pT stages, a prospective multicenter report. World J Urol (2016) 0.75
Sentinel lymph node biopsy in oral and oropharyngeal squamous cell carcinoma: current status and unresolved challenges. Eur J Nucl Med Mol Imaging (2015) 0.75
Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial. J Clin Oncol (1996) 2.61
Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancer. Eur J Cancer (2003) 2.40
Patients with penile carcinoma benefit from immediate resection of clinically occult lymph node metastases. J Urol (2005) 2.31
Systematic review and meta-analysis of laparoscopic versus open colectomy with end ileostomy for non-toxic colitis. Br J Surg (2013) 2.11
Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer. Br J Surg (2013) 1.98
Dermatofibrosarcoma protuberans: treatment and prognosis. Eur J Surg Oncol (1992) 1.87
Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy. J Am Coll Surg (2001) 1.79
Reliability of sentinel lymph node biopsy for staging melanoma. Br J Surg (2000) 1.71
Positive iliac and obturator nodes in melanoma: survival and prognostic factors. Ann Surg Oncol (1999) 1.55
Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs. J Am Coll Surg (1996) 1.54
Lymph node metastasis from melanoma with an unknown primary site. Br J Surg (1990) 1.49
Clear cell sarcoma (malignant melanoma) of soft parts: A clinicopathologic study of 30 cases. Cancer (1999) 1.46
[Identification of the sentinel node in patients with breast carcinoma]. Ned Tijdschr Geneeskd (1996) 1.42
Evaluation of mammary lymphoscintigraphy by a single intratumoral injection for sentinel node identification. J Nucl Med (2000) 1.25
Prognostic factors for tumor response and limb recurrence-free interval in patients with advanced melanoma of the limbs treated with regional isolated perfusion with melphalan. Surgery (1994) 1.23
Frozen section investigation of the sentinel node in malignant melanoma and breast cancer. Ann Surg Oncol (2001) 1.19
Perineal hernia repair after abdominoperineal resection: a pooled analysis. Colorectal Dis (2012) 1.18
Localizing the sentinel node in cutaneous melanoma: gamma probe detection versus blue dye. Ann Surg Oncol (1997) 1.13
Regional perfusion treatment with melphalan for melanoma in a limb: an evaluation of drug kinetics. Eur J Surg Oncol (1988) 1.10
Response to Jensen et al. (2014): pelvic floor reconstruction with a biological mesh after extralevator abdominoperineal excision leads tolow wound complications and perineal hernia rates with minor movement limitations. Colorectal Dis (2014) 1.06
Factors determining delay in relaparotomy for anastomotic leakage after colorectal resection. World J Gastroenterol (2007) 1.06
Surgery for melanoma metastatic to the gastrointestinal tract. Br J Surg (1990) 1.06
History of sentinel node and validation of the technique. Breast Cancer Res (2001) 1.05
Single intralesional tracer dose for radio-guided excision of clinically occult breast cancer and sentinel node. Ann Surg Oncol (2001) 1.04
Bridge-to-surgery stent placement versus emergency surgery for acute malignant colonic obstruction. Br J Surg (2014) 1.02
Oncological outcome of malignant colonic obstruction in the Dutch Stent-In 2 trial. Br J Surg (2014) 1.00
VWF release and platelet aggregation in human melanoma after perfusion with TNF alpha. J Pathol (1995) 0.98
Altered lymphatic drainage after lymphadenectomy or radiotherapy of the axilla in patients with breast cancer. Br J Surg (1996) 0.97
Lymphatic mapping and sentinel lymph node biopsy in breast cancer. Eur J Nucl Med (1999) 0.97
Vascular complications of isolated limb perfusion. Eur J Surg Oncol (1998) 0.97
Reliability of lymphoscintigraphy in indicating the number of sentinel nodes in melanoma patients. Ann Surg Oncol (2000) 0.96
Long-term morbidity after regional isolated perfusion with melphalan for melanoma of the limbs. The influence of acute regional toxic reactions. Arch Surg (1995) 0.96
Sentinel node biopsy for melanoma in the head and neck region. Head Neck (2000) 0.96
Severe acute regional toxicity after normothermic or 'mild' hyperthermic isolated limb perfusion with melphalan for melanoma. Melanoma Res (1995) 0.93
Sentinel nodes outside lymph node basins in patients with melanoma. Br J Surg (2001) 0.93
Melphalan tissue concentrations in patients treated with regional isolated perfusion for melanoma of the lower limb. Br J Cancer (1994) 0.91
Epithelioid sarcoma. Eur J Surg Oncol (1989) 0.90
Thirty-five years of isolated limb perfusion for melanoma: indications and results. Br J Surg (1996) 0.90
Relation between limb toxicity and treatment outcomes after isolated limb perfusion for recurrent melanoma. J Am Coll Surg (1999) 0.90
Identification and biopsy of the sentinel lymph node in breast cancer. Eur J Surg Oncol (1998) 0.90
Results of regional isolation perfusion with cytostatics in patients with soft tissue tumors of the extremities. Cancer (1989) 0.90
Absence of severe systemic toxicity after leakage-controlled isolated limb perfusion with tumor necrosis factor-alpha and melphalan. Ann Surg Oncol (1999) 0.89
Lymphatic mapping with intralesional tracer administration in breast carcinoma patients. Cancer (2000) 0.89
Complications of combined radiotherapy and isolated limb perfusion with tumor necrosis factor alpha +/- interferon gamma and melphalan in patients with irresectable soft tissue tumors. J Surg Oncol (1997) 0.88
Toxicity and morbidity of isolated limb perfusion. Semin Surg Oncol (1998) 0.88
Early reconstruction of the leaking ileal pouch-anal anastomosis: a novel solution to an old problem. Colorectal Dis (2015) 0.87
Initial experiences of simultaneous laparoscopic resection of colorectal cancer and liver metastases. HPB Surg (2012) 0.87
Improved sentinel node visualization in breast cancer by optimizing the colloid particle concentration and tracer dosage. Nucl Med Commun (2001) 0.87
Lymph node metastases in the neck and parotid gland from an unknown primary melanoma. Clin Otolaryngol Allied Sci (1994) 0.86
Isolated perfusion of the limb with high-dose tumour necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma) and melphalan for melanoma stage III. Results of a multi-centre pilot study. Melanoma Res (1994) 0.86
Long-term functional morbidity after mild hyperthermic isolated limb perfusion with melphalan. Eur J Surg Oncol (1999) 0.86
Recurrent volvulus of the transverse colon after sigmoid resection. Int J Colorectal Dis (2008) 0.85
Hyperthermic isolated limb perfusion with tumor necrosis factor alpha, interferon gamma, and melphalan for locally advanced nonmelanoma skin tumors of the extremities: a multicenter study. Arch Surg (1999) 0.85
Patient- and treatment-related factors associated with acute regional toxicity after isolated perfusion for melanoma of the extremities. Am J Surg (1994) 0.85
Normothermic isolation perfusion with melphalan for advanced melanoma of the limbs. Anticancer Res (1987) 0.85
Isolated limb perfusion with high-dose tumor necrosis factor-alpha for locally advanced extremity soft tissue sarcomas. Cancer Treat Res (1997) 0.85
A retrospective comparative study evaluating the results of mild hyperthermic versus controlled normothermic perfusion for recurrent melanoma of the extremities. Eur J Cancer (1995) 0.85
Evaluating national practice of preoperative radiotherapy for rectal cancer based on clinical auditing. Eur J Surg Oncol (2013) 0.84
Management of clinically node negative penile carcinoma: improved survival after the introduction of dynamic sentinel node biopsy. J Urol (2003) 0.84
Is lymphatic mapping in breast cancer adequate and safe? World J Surg (2001) 0.84
Regional toxicity after isolated limb perfusion with melphalan and tumour necrosis factor- alpha versus toxicity after melphalan alone. Eur J Surg Oncol (2001) 0.84
Lymphatics of the breast and the rationale for different injection techniques. Ann Surg Oncol (2001) 0.84
Technique of sentinel node biopsy in breast cancer. Eur J Surg Oncol (1998) 0.84
Lymphoscintigraphy in oncology: a rediscovered challenge. Eur J Nucl Med (1999) 0.83
Systemic leakage during isolated limb perfusion for melanoma. Br J Surg (1993) 0.83
Limb recurrence-free interval and survival in patients with recurrent melanoma of the extremities treated with normothermic isolated perfusion. J Am Coll Surg (1994) 0.83
Intestinal obstruction due to diffuse peritoneal fibrosis at 2 years after the successful treatment of malignant peritoneal mesothelioma with intraperitoneal mitoxantrone. Cancer Chemother Pharmacol (1992) 0.83
Isolated limb perfusion in primary and recurrent melanoma: indications and results. Semin Surg Oncol (1998) 0.82
False negative sentinel node procedure established through palpation of the biopsy wound. Eur J Surg Oncol (2000) 0.82
Reproducibility of lymphoscintigraphy for lymphatic mapping in cutaneous melanoma. J Nucl Med (1996) 0.82
Radiological evaluation of colorectal anastomoses. Int J Colorectal Dis (2008) 0.82
Lymph node size as a predictor of lymphatic staging in colonic cancer. Br J Surg (2014) 0.81
Sensitivity of sentinel node biopsy in melanoma. J Surg Oncol (2001) 0.81
Results of radical dissection of the groin in patients with stage II melanoma and histologically proved metastases of the iliac or obturator lymph nodes, or both. Surg Gynecol Obstet (1988) 0.81
Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy. Cancer (1999) 0.81
Validation of gamma probe detection of the sentinel node in melanoma. J Nucl Med (1997) 0.81
[Characteristics of patients with recurrence of primary melanoma at least 10 years following surgical treatment]. Ned Tijdschr Geneeskd (1994) 0.80
Is there an indication for a double perfusion schedule with melphalan for patients with recurrent melanoma of the limbs? Melanoma Res (1994) 0.80
Isolation limb perfusion with tumor necrosis factor alpha and chemotherapy for advanced extremity soft tissue sarcomas. Semin Oncol (1997) 0.79
Radio-guided surgery improves outcome of therapeutic excision in non-palpable invasive breast cancer. Nucl Med Commun (2004) 0.79
[Revised consensus melanoma of the skin]. Ned Tijdschr Geneeskd (1990) 0.79
[Three men with breast cancer]. Ned Tijdschr Geneeskd (2005) 0.78
To perfuse or not to perfuse? A retrospective comparative study to evaluate the effect of adjuvant isolated regional perfusion in patients with stage I extremity melanoma with a thickness of 1.5 mm or greater. J Clin Oncol (1988) 0.78
The value of Cloquet's node in predicting melanoma nodal metastases in the pelvic lymph node basin. Ann Surg Oncol (2001) 0.78
Physiological implications of hyperbaric oxygen tensions in isolated limb perfusion using melphalan: a pilot study. Eur Surg Res (1996) 0.78
Comparison between the use of whole blood versus a diluted perfusate in regional isolated perfusion by continuous monitoring of transcutaneous oxygen tension: a pilot study. J Invest Surg (1994) 0.78
Results of regional isolated perfusion for locally inoperable melanoma of the limbs. Melanoma Res (1994) 0.78
Systemic toxicity after isolated limb perfusion with melphalan for melanoma. Eur J Surg Oncol (1996) 0.78
Improved staging of breast cancer through lymphatic mapping and sentinel node biopsy. Eur J Surg Oncol (1998) 0.78
Controversies concerning adjuvant regional isolated perfusion for stage I melanoma of the extremities. World J Surg (1992) 0.77
Short-term morbidity and quality of life from a randomized clinical trial of close rectal dissection and total mesorectal excision in ileal pouch-anal anastomosis. Br J Surg (2014) 0.77
[Alveolar soft tissue sarcoma]. Ned Tijdschr Geneeskd (1981) 0.77
Value of laboratory tests in monitoring acute regional toxicity after isolated limb perfusion. Ann Surg Oncol (1997) 0.77
Surgery for Crohn's disease: new developments. Dig Surg (2012) 0.77
Hyperthermic isolated limb perfusion with tumour necrosis factor and melphalan as treatment of locally advanced or recurrent soft tissue sarcomas of the extremities. Radiother Oncol (1998) 0.77